Search
for
Sort by
Research 30 of 1000+
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Male breast cancer after finasteride therapy for benign prostate hyperplasia
- Ductal breast cancer in a male patient
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Male alopecia, finasteride, and cancer risk
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
- How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss
- Aromatase inhibitors induce ‘male pattern hair loss’ in women?
- Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- 5α-Reductase inhibitors in androgenetic alopecia
- Further research needed if finasteride is to become standard of care for frontal fibrosing alopecia (FFA)
- A cornerstone of hematological science
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Notes from the Editor Emeritus: Finasteride: the downtrodden hero of hair transplantation emerges once again
- Transmasculine Hormone Therapy
- Potential Pharmacological Activities of Pumpkin Seeds as a Functional Food: A Comprehensive Review
- Researchers Link Early Hair Loss and Prostate Cancer
- Androgen receptor: A promising therapeutic target in breast cancer
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Hormone Blocking Anticancer Drugs
- British Menopause Society Tools for Clinicians: Testosterone replacement in menopause.
- Testosterone: The Male Sex Hormone
- Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual‐level data from Denmark, Finland, and Sweden